ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Machine Learning Scientist II, Drug Discovery Analytics at Revolution Medicines - ApplyBlast

Machine Learning Scientist II, Drug Discovery Analytics

Revolution Medicines

3 hours ago

3.5 on Glassdoor

Redwood City, California, United States

Hybrid

Full Time

Medior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Revolution Medicines is seeking a Machine Learning Scientist II to accelerate drug discovery through advanced analytics and artificial intelligence. This role involves developing predictive models and analytical methods to transform complex biological and chemical datasets into actionable insights for research teams. The position supports target discovery, compound optimization, phenotypic screening, and translational research by collaborating with data scientists, chemists, and biologists.

Responsibilities

Develop and evaluate machine learning models for drug discovery
Perform exploratory data analysis on chemical and biological datasets
Collaborate with cross-functional scientific partners to translate research questions

Skills

Qualifications

Ph.D. in machine learning, computational biology, computational chemistry, computer science, statistics, bioinformatics, or a related quantitative fieldM.S. degree with relevant industry experience

About Revolution Medicines

revmed.com

Headquarters

Redwood City, California, United States

Company Size

201-500 employees

Founded

2014

View Profile

Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.